Patent directory · USPTO A61K / A61P
Patents matching “VACCINEX, INC.”
41 pharma patents match "VACCINEX, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 41 pharmaceutical patents matching "VACCINEX, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9676840
Anti-CD100 neutralizing antibodies and methods of using the same
granted -
US 9603922
Modulation of NKT cell activity with antigen-loaded CD1d molecules
granted -
US 9605055
Anti-CD100 antibodies and methods of using the same
granted -
US 9598495
Use of semaphorin-4D binding molecules for treating neurodegenerative disorders
granted -
US 9512224
Use of semaphorin-4D binding molecules for treatment of atherosclerosis
granted -
US 9382327
Anti-CD20 antibodies and methods of use
granted -
US 9371352
Modified glycolipids and methods of making and using the same
granted -
US 9249227
Use of semaphorin-4D binding molecules for treating neurodegenerative disorders
granted -
US 9243068
Combination of SEMA-4D inhibitors and immunomodulators to inhibit tumors and metastases
granted -
US 8834883
Anti-VEGF antibodies and uses thereof
granted -
US 8816058
Polynucleotides encoding anti-CD100 antibodies or antigen-binding fragments thereof
granted -
US 8790652
Use of the combination of semaphorin-4D inhibitory molecules and VEGF inhibitory molecules to inhibit angiogenesis
granted -
US 8637026
Anti-C35 antibody combination therapies and methods
granted -
US 8496938
Anti-CD100 neutralizing neutralizing antibodies and methods of using the same
granted -
US 7919594
Human anti-CD100 antibodies
granted -
US 7919095
Anti-IL-6 monoclonal antibodies
granted -
US 7807168
Selection of human TNFα specific antibodies
granted